Medical sales rep salary: what the field pays across devices, pharma and diagnostics

"Medical sales" is used as if it were a single career, which is why salary figures for it vary so wildly depending on where you read them. It covers at least four distinct jobs with different buyers, different cycles and different pay structures.

Sorting them out is the first step to reading any number you find about the field.

The four fields, compared

Treat these as ranges rather than medians, and check them against a live compensation source before you use them in a negotiation. Every one of them moves with territory, tenure and the specific product line.

Why the fields pay differently

Pharmaceutical: influence, not transactions

A pharma rep does not close a sale. There is no contract signed at the end of a call. The rep's job is to influence prescribing behaviour over time, in a heavily regulated context that dictates what can be said and how often a physician can be visited.

Because the outcome is indirect and slow, pay is structured around a high, stable base with a bonus tied to territory prescription growth rather than to individual deals. That produces a comfortable floor and a low ceiling. A pharma rep rarely has a catastrophic year, and rarely has a spectacular one.

Medical device: a transaction with a clinical buyer

Device sales has an actual purchase at the end. Someone signs something. That makes commission meaningful, and it moves the structure toward an even split.

Within devices, the split that matters is surgical versus everything else. Non-surgical device sales looks like ordinary B2B: appointments, evaluations, procurement. Surgical device sales requires the rep to be in the operating room, often on short notice, sometimes overnight, advising on instrumentation during procedures. The pay is higher because the job intrudes on your life in ways a territory sales job does not.

Capital equipment: few deals, large deals

Imaging systems, surgical robots, lab analysers. A rep might close a handful of deals a year, each worth hundreds of thousands or millions. Cycles run twelve to twenty-four months and involve hospital finance, clinical committees and sometimes board approval.

Base salaries here are often lower relative to total compensation, and the variance between reps is enormous. One deal slipping from December to February moves a rep's year by six figures.

Diagnostics and lab

Sells to pathologists, laboratory directors and health system procurement. Contracts are often multi-year and volume-based, which produces steadier commission than capital equipment but a lower ceiling than surgical devices.

What actually determines your number

Territory. The single most underrated factor. Two reps with identical titles, at the same company, on the same plan, can earn sixty thousand dollars apart because one covers a region with three high-volume surgical centres and the other covers a rural territory with a fraction of the procedure count. Ask about historical territory performance before you accept.

Whether the territory is established or greenfield. Inheriting a book with existing accounts is a completely different first year from opening a territory with no installed base. Greenfield roles should come with either a longer ramp, a larger draw, or both.

Tenure and relationships. Clinical buyers are slow to trust and slow to switch. A rep with five years of relationships in a territory closes business that a new rep cannot access at any price. This is why medical sales rewards staying put more than most sales careers do.

Product line. Within the same company, a rep on a flagship line with strong clinical evidence has a fundamentally easier year than a rep launching a challenger product against an entrenched standard of care.

Getting in

The field has a reputation for being hard to enter, and it is, but not for the reason most people assume. Companies are not primarily looking for clinical backgrounds. They are looking for evidence that you can run a territory: documented quota attainment, an ability to hold a technical conversation, and a tolerance for a long, relationship-driven cycle.

The common routes in are a business-to-business sales role with documented results, an associate or clinical specialist position that converts to a territory after twelve to eighteen months, or a clinical role moving across into commercial.

Before you accept an offer

1. What did this territory produce in each of the last two years?
2. Is it established or greenfield, and what is the ramp?
3. Is the draw recoverable?
4. What share of the total is base, and what triggers the bonus?
5. What is the call coverage expectation, and how is it compensated?
6. How much overnight travel does the territory actually require?

Questions one and six are the ones that separate a good offer from an offer that looks good.